Coumarin and Piperazine Conjugates as Selective Inhibitors of the Tumor-associated Carbonic Anhydrase IX and XII Isoforms.


Journal

Anti-cancer agents in medicinal chemistry
ISSN: 1875-5992
Titre abrégé: Anticancer Agents Med Chem
Pays: Netherlands
ID NLM: 101265649

Informations de publication

Date de publication:
2023
Historique:
received: 10 09 2022
revised: 02 12 2022
accepted: 08 12 2022
medline: 6 6 2023
pubmed: 4 2 2023
entrez: 3 2 2023
Statut: ppublish

Résumé

Carbonic Anhydrases (CAs) are a family of metalloenzymes that catalyze the reversible interconversion of CO The objective of this study is to synthesize potent and selective tumor-associated CA IX and XII inhibitors. A library of 17 coumarin derivatives clubbed with piperazine and benzyl moiety was designed, synthesized and evaluated for its inhibitory effects and selectivity profile towards physiologically and pharmacologically relevant CA isoforms I, II, IX, and XII. All the derivatives were found to be active against the tumor-associated isoforms IX and XII. The most active compound against hCA (human Carbonic Anhydrase) IX was found to possess a K Coumarin-piperazine hybrids were identified as potent and selective CA IX and XII inhibitors. Molecular modeling techniques provided interesting cues pertaining to observed selectivity.

Sections du résumé

BACKGROUND
Carbonic Anhydrases (CAs) are a family of metalloenzymes that catalyze the reversible interconversion of CO
OBJECTIVE
The objective of this study is to synthesize potent and selective tumor-associated CA IX and XII inhibitors.
METHODS
A library of 17 coumarin derivatives clubbed with piperazine and benzyl moiety was designed, synthesized and evaluated for its inhibitory effects and selectivity profile towards physiologically and pharmacologically relevant CA isoforms I, II, IX, and XII.
RESULTS
All the derivatives were found to be active against the tumor-associated isoforms IX and XII. The most active compound against hCA (human Carbonic Anhydrase) IX was found to possess a K
CONCLUSION
Coumarin-piperazine hybrids were identified as potent and selective CA IX and XII inhibitors. Molecular modeling techniques provided interesting cues pertaining to observed selectivity.

Identifiants

pubmed: 36733240
pii: ACAMC-EPUB-129240
doi: 10.2174/1871520623666230202123535
doi:

Substances chimiques

Carbonic Anhydrase IX EC 4.2.1.1
Carbonic Anhydrase Inhibitors 0
Isoenzymes 0
Antigens, Neoplasm 0
Coumarins 0
Piperazines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1184-1191

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Aaftaab Sethi (A)

Department of Medicinal Chemistry, National Institute of Pharmaceutical Education & Research, Hyderabad, Balanagar, India.

Sharon Munagalasetty (S)

Department of Medicinal Chemistry, National Institute of Pharmaceutical Education & Research, Hyderabad, Balanagar, India.

Mohammed Arifuddin (M)

Department of Medicinal Chemistry, National Institute of Pharmaceutical Education & Research, Hyderabad, Balanagar, India.
Department of Chemistry, Directorate of Distance Education, Maulana Azad National Urdu University, Gachibowli, Hyderabad, 500032, T.S. India.

Simone Carradori (S)

Department of Pharmacy, G. d'Annunzio University of Chieti-Pescara, 66100, Chieti, Italy.

Claudiu T Supuran (CT)

Neurofarba Department, Sezione di Scienze Farmaceutiche e Nutraceutiche, Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Sesto Fiorentino, Florence, 50019, Italy.

Ravi Alvala (R)

Department of Biotechnology, G. Pulla Reddy College of Pharmacy, Mehdipatnam, Hyderabad, 500028, Telangana, India.

Mallika Alvala (M)

Department of Medicinal Chemistry, National Institute of Pharmaceutical Education & Research, Hyderabad, Balanagar, India.
MARS Training Academy, Hyderabad, 500028, Telangana, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH